NCT02149108 2017-07-21Nintedanib (BIBF 1120) vs Placebo in Refractory Metastatic Colorectal Cancer (LUME-Colon 1)Boehringer IngelheimPhase 3 Completed768 enrolled 10 charts
NCT00904839 2015-02-04BIBF 1120 Versus Bevacizumab in Metastatic Colorectal CancerBoehringer IngelheimPhase 2 Completed128 enrolled 21 charts